Sawit Sumbermas Sarana Tbk (SSMS)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 820.00 |
|---|---|
| 52-week range | 650.00 – 1,713.10 |
| Return, 1 month / 3 months | −30.5% / −11.8% |
| Return, 1 year / 3 years | −45.9% / −24.9% |
| Trend | Below its 200-day average |
| RSI (14) | 27 |
| Volatility (1 year) | 58.6% |
| Worst drawdown (1 year) | -60.9% |
| Average daily value traded | 11,086.94M IDR |
| Dividend yield | 10.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sawit Sumbermas Sarana is an Indonesian plantation company that grows oil palms and processes the fruit into crude palm oil and palm kernel at its own mills. Its estates and processing operations are located in Central Kalimantan, and its customers are the refiners, traders and manufacturers that use palm oil and palm kernel as raw materials for food, consumer goods and industrial products. The company also operates in the downstream palm sector.
On this site Sawit Sumbermas Sarana Tbk appears as a stock on the Jakarta Exchange (Indonesia), code SSMS, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sawit Sumbermas Sarana Tbk (SSMS) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 820.00 on 19 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 490 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 45.9% and over the last three months it fell 11.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -27.7% | ||
| From 52-week high | -52.1% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.8% | ||
| 6-month return | -36.9% | ||
| 12-month return, skipping the last month | -22.1% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -60.9% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 11,086.94M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 10.2% | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −22.3% |
|---|---|
| 1 month | −30.5% |
| 3 months | −11.8% |
| 6 months | −36.9% |
| 1 year | −45.9% |
| 3 years | −24.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1,030.80 / 1,134.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 59.60 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2026 | IDR 83.9900 |
| 30 Apr 2025 | IDR 47.2400 |
| 17 May 2023 | IDR 74.6400 |
| 12 Oct 2022 | IDR 74.6400 |
| 3 Jun 2022 | IDR 80.1500 |
| 9 Jun 2021 | IDR 30.4900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.